Immediate Impact
3 from Science/Nature 53 standout
Citing Papers
Cancer therapy with antibodies
2024 Standout
T-cell-engaging bispecific antibodies in cancer
2023 Standout
Works of Qiming Liao being referenced
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Qiming Liao | 566 | 483 | 242 | 41 | 1.1k | |
| Zhiyuan Liu | 350 | 562 | 43 | 53 | 1.4k | |
| P. T. A. Schellekens | 228 | 237 | 64 | 40 | 1.0k | |
| Francesca Incardona | 266 | 269 | 21 | 48 | 1.2k | |
| Haruhiko Murata | 475 | 414 | 31 | 25 | 1000 | |
| Carlos A. Luciano | 240 | 105 | 94 | 32 | 1.3k | |
| Christina Gavegnano | 458 | 485 | 21 | 32 | 936 | |
| Isabelle Girault | 177 | 316 | 45 | 39 | 1.2k | |
| Yonghong Zhang | 380 | 144 | 54 | 110 | 1.3k | |
| Li Li | 176 | 48 | 53 | 50 | 1.3k | |
| Eva Riveira‐Muñoz | 309 | 423 | 44 | 53 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...